According to the ELN and NCCN guidelines, RUNX1, ASXL1, TP53, FLT3-ITD, NPM1 and biCEBPA mutations have been involved in AML prognostic stratification2,3. This evidence concerns the gene TP53 and acute myeloid leukemia.